Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013430 |
---|---|
Receipt number | R000015680 |
Scientific Title | A phase II study of adjuvant chemotherapy with 5-FU and heparin-based portal infusion chemotherapy followed by TS-1 for patients with resected pancreatic cancer (TOSPAC-02) |
Date of disclosure of the study information | 2014/03/15 |
Last modified on | 2018/03/23 01:51:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/03/15 01:29:22 | ||
2 | Update | 2015/04/05 15:38:51 | UMIN ID2 |
|
3 | Update | 2015/04/08 11:04:48 | Email Email1 |
|
4 | Update | 2015/05/30 15:22:22 | Institutions |
|
5 | Update | 2015/05/30 15:23:02 | UMIN ID1 |
|
6 | Update | 2015/06/03 11:35:43 | Institutions |
|
7 | Update | 2016/05/09 22:02:52 | UMIN ID3 |
|
8 | Update | 2017/10/02 13:28:06 | UMIN ID1 |
|
9 | Update | 2017/10/02 13:36:36 | Target sample size |
|
10 | Update | 2017/10/02 13:40:00 | Name of primary person or sponsor Organization |
|
11 | Update | 2017/10/14 19:27:54 | Recruitment status |
|
12 | Update | 2018/03/23 01:51:34 | Recruitment status |